Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_assertion type Assertion NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_head.
- NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_assertion description "[Expressions of 5- and 12-LOX in prostate cancer (PC) patients, prostatic intraepithelial neoplasia (PIN), benign prostatic hyperplasia (BPH), and normal prostate (NP) tissues were examined, as well as effects of their inhibitors on cell proliferation in 2 PC cell lines (PC3, DU-145).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_provenance.
- NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_assertion evidence source_evidence_literature NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_provenance.
- NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_assertion SIO_000772 15010818 NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_provenance.
- NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_assertion wasDerivedFrom befree-20150227 NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_provenance.
- NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_assertion wasGeneratedBy ECO_0000203 NP235950.RAX_6nmH-bv-TJpGB2xuDNA8ncZvcvJXXWsuv5_BV0S14130_provenance.